semaglutide compounding pharmacy lawsuit The Risks of Compounded Products How the FDA's Semaglutide Ruling

Rulemaking timelines are unpredictable

It is possible that between 2017 and 2021 there were many deaths attributable to GLP-1As overlooked by the NPDS

These are called bellwether trials. The courts goal is that these few trials can result in a settlement program without having to hold trials for each of the thousands of cases that are filed

NICE recommends it (Technology Appraisal TA875) for adults with a BMI of 35 kg/m or above with at least one weight-related comorbidity, or a BMI of 3034.9 kg/m in certain higher-risk groups, when used within a specialist Tier 3 or Tier 4 weight management service alongside a reduced-calorie diet and increased physical activity

As we await further clinical trials, real-world patient reports via surveys can provide quick and direct insights into which therapeutic interventions may or may not be beneficial